Basic Information
| LncRNA/CircRNA Name | LOC730101 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | osteosarcoma tissues |
| Expression Pattern | up-regulated |
| Function Description | We found that LOC730101 was significantly upregulated in human osteosarcoma tissues compared with corresponding adjacent normal tissues. Elevated LOC730101 expression was correlated with advanced clinical stage (p = 0.001) and distant metastasis (p = 0.005). multivariate analysis showed that LOC730101 maintained an independent prognostic influence on overall survival (p = 0.006). |
| Pubmed ID | 30024599 |
| Year | 2018 |
| Title | High Expression of Long Non-Coding RNA LOC730101 Correlates With Distant Metastasis and Exhibits a Poor Prognosis in Patients With Osteosarcoma. |
External Links
| Links for LOC730101 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |